Merck Gets Win In Patent Suit Over Diabetes Drugs

By Adam Lidgett (September 22, 2022, 5:44 PM EDT) -- A West Virginia federal judge has found that Mylan Pharmaceuticals Inc.'s planned generics of a pair of multibillion-dollar-selling diabetes drugs sold by Merck & Co. Inc. would infringe Merck's patents on the products....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!